Miralac

Dosage form: tablet
Ingredients: CALCIUM CARBONATE 420mg
Labeler: Honeywell Safety Products USA, Inc
NDC code: 0498-0303

Medically reviewed by Drugs.com. Last updated on Jan 9, 2025.

Miralac

Active ingredient (in each chewable tablet)

Calcium carbonate 420 mg

Purpose

Antacid

Uses

for the relief of

acid indigestion
heartburn
sour stomach
upset stomach associated with these symptoms

Warnings

Ask a doctor before use if you have

kidney stones
calcium-restricted diet

Ask a doctor before use if you are

presently taking a prescription drug. Antacids may interfere with certain prescription drugs

When using this product

do not take more than 12 tablets in a 24- hour period, or use the maximum dosage of this product for more than 2 weeks, except under the advice and supervision of a doctor.

Keep out of the reach of children.

In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Directions

chew 1 to 2 tablets every 4 hours as symptoms occur, or as directed by a doctor.

Other information

each tablet contains: calcium 170 mg
sucrose free
lactose free
store at room temperature
TAMPER EVIDENT PACKETS- DO NOT USE IF OPEN OR TORN

Inactive ingredients

magnesium stearate, mint flavor, silicon dioxide, sorbitol, starch

Questions or comments?

1-800-430-5490

Principal Display Panel

MIRALAC
calcium carbonate tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0498-0303
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CALCIUM CARBONATE (CALCIUM CATION and CARBONATE ION)	CALCIUM CARBONATE	420 mg

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE
SILICON DIOXIDE
SORBITOL
STARCH, CORN

Product Characteristics
Color	white (White)	Score	2 pieces
Shape	ROUND	Size	11mm
Flavor	MINT (Mint Flavor)	Imprint Code	FR8
Contains

Packaging
#	Item Code	Package Description
1	NDC:0498-0303-10	100 PACKET in 1 BOX, UNIT-DOSE
1		2 TABLET in 1 PACKET
2	NDC:0498-0303-25	250 PACKET in 1 BOX, UNIT-DOSE
2		2 TABLET in 1 PACKET
3	NDC:0498-0303-50	500 BOX, UNIT-DOSE in 1 BOX, UNIT-DOSE
3		2 TABLET in 1 BOX, UNIT-DOSE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part331	02/22/2012

Labeler - Honeywell Safety Products USA, Inc (079287321)

Registrant - Honeywell Safety Products USA, Inc (079287321)

Establishment
Name	Address	ID/FEI	Operations
Honeywell Safety Products USA, Inc		079287321	repack(0498-0303)

Revised: 01/2020

Document Id: 9c87da20-de20-ed22-e053-2995a90a55e9

Set id: 7ccb324f-b12b-4867-87d5-b444e0c5b9a5

Version: 11

Effective Time: 20200119

Honeywell Safety Products USA, Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Miralac

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport